Correlation Between Veracyte and PharmaCyte Biotech
Can any of the company-specific risk be diversified away by investing in both Veracyte and PharmaCyte Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and PharmaCyte Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and PharmaCyte Biotech, you can compare the effects of market volatilities on Veracyte and PharmaCyte Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of PharmaCyte Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and PharmaCyte Biotech.
Diversification Opportunities for Veracyte and PharmaCyte Biotech
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Veracyte and PharmaCyte is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and PharmaCyte Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PharmaCyte Biotech and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with PharmaCyte Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PharmaCyte Biotech has no effect on the direction of Veracyte i.e., Veracyte and PharmaCyte Biotech go up and down completely randomly.
Pair Corralation between Veracyte and PharmaCyte Biotech
Given the investment horizon of 90 days Veracyte is expected to generate 0.67 times more return on investment than PharmaCyte Biotech. However, Veracyte is 1.5 times less risky than PharmaCyte Biotech. It trades about 0.19 of its potential returns per unit of risk. PharmaCyte Biotech is currently generating about 0.01 per unit of risk. If you would invest 2,995 in Veracyte on August 28, 2025 and sell it today you would earn a total of 1,776 from holding Veracyte or generate 59.3% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 93.75% |
| Values | Daily Returns |
Veracyte vs. PharmaCyte Biotech
Performance |
| Timeline |
| Veracyte |
| PharmaCyte Biotech |
Veracyte and PharmaCyte Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Veracyte and PharmaCyte Biotech
The main advantage of trading using opposite Veracyte and PharmaCyte Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, PharmaCyte Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PharmaCyte Biotech will offset losses from the drop in PharmaCyte Biotech's long position.| Veracyte vs. CITIC Telecom International | Veracyte vs. B Communications | Veracyte vs. Smith Micro Software | Veracyte vs. CyberArk Software |
| PharmaCyte Biotech vs. Collins Foods Limited | PharmaCyte Biotech vs. Salesforce | PharmaCyte Biotech vs. ConAgra Foods | PharmaCyte Biotech vs. 51Talk Online Education |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |